Abstract
Most of the ethical aspects of personalized medicine are based on pharmacogenetics, genetic screening and impact on healthcare. Understanding the social effects of genomics requires an analysis of the ways in which genetic information and a genetic approach to disease affect people individually, within their families and communities, and in their social and working lives. This information will lead to measures for the prevention of stigmatization and discrimination of different populations on ethnic grounds.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Annes JP, Giovanni MA, Murray MF. Risks of presymptomatic direct-to-consumer genetic testing. NEJM. 2010;363:1100–1.
Bloss CS, Schork NJ, Topol EJ. Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med. 2011;364:524–34.
Caulfield T, McGuire AL, Cho M, et al. Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol. 2008;6:e73.
Chandrasekharan S, Cook-Deegan R. Gene patents and personalized medicine – what lies ahead? Genome Med. 2009;1:92.
Cohen JC, Boerwinkle E, Mosley Jr TH, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. NEJM. 2006;354:1264–72.
Geransar R, Einsiedel E. Evaluating online direct-to-consumer marketing of genetic tests: informed choices or buyers beware? Genet Test. 2008;12:13–23.
Hudson KL, Holohan MK, Collins FS. Keeping pace with the times – the genetic information nondiscrimination act of 2008. NEJM. 2008;358:2661–3.
Hunter DJ, Khoury MJ, Drazen JM. Letting the genome out of the bottle – will we get our wish? N Engl J Med. 2008;358:105–7.
James KM, Cowl CT, Tilburt JC, et al. Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic. Mayo Clin Proc. 2011;86:933–40.
Offit K. Genomic profiles for disease risk: predictive or premature? JAMA. 2008;299:1353–5.
Sherkow JS, Greely HT. The future of gene patents and the implications for medicine. JAMA Intern Med. 2013;173:1569–70.
So D, Joly Y. Commercial opportunities and ethical pitfalls in personalized medicine: a Myriad of reasons to revisit the Myriad Genetics Saga. Curr Pharmacogenomics Pers Med. 2013;11:98–109.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Jain, K.K. (2015). Ethical Aspects of Personalized Medicine. In: Textbook of Personalized Medicine. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2553-7_21
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2553-7_21
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2552-0
Online ISBN: 978-1-4939-2553-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)